Apr 2024 Novel Psychoactive Substance Trends in 2023
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of prescription or illicit...
In Practice: Clinical Insights
Mar 2024 Detection of NPS in Buprenorphine Samples
Aegis recently conducted a retrospective analysis of patient samples from individuals who were prescribed buprenorphine to ascertain how frequently novel...
Feb 2024 Medication Monitoring in Behavioral Health
Mental illness is common in the United States, with an estimated 52.9 million people – about 1 in 5 adults...
Jan 2024 BioDetect: Identifying Non-Urine Substances
Healthcare providers rely on medication adherence test results to assist in measuring compliance and evaluating recent substance use. Providers must...
Dec 2023 An Overview of Testing Capabilities to Identify Use of Marijuana (THC) and Other Natural Cannabinoids
Following the passing of the 2018 Agriculture Improvement Act (a.k.a. Farm Bill), the cannabis industry has seen widespread growth in...
Nov 2023 Synthetic Stimulants
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of scheduled or illicit...
